Eupraxia Pharmaceuticals Inc. (EPRX) vs YD Bio Limited (YDES)

Eupraxia Pharmaceuticals Inc. EPRX 6.75 −1.89%
YD Bio Limited YDES 6.98 +9.06%

Eupraxia Pharmaceuticals Inc. and YD Bio Limited are both Biotechnology companies. Eupraxia Pharmaceuticals Inc. and YD Bio Limited are of similar size ($453.0M and $447.3M).

Metric	EPRX	YDES	Biotechnology median
P/E	n/m	—	10.64
P/S	n/m	—	9.59
P/B	4.56	—	2.15
Price to free cash flow	n/m	—	26.07
EV/EBITDA	n/m	—	0.65
EV/Sales	n/m	—	9.45
Earnings yield	(14.34%)	—	(34.69%)
Free cash flow yield	(8.38%)	—	(24.02%)

Metric	EPRX	YDES	Biotechnology median
Gross margin	—	—	65.59%
Operating margin	0.00%	—	0.00%
Net margin	0.00%	—	0.00%
Free cash flow margin	0.00%	—	0.00%
Return on equity	(117.82%)	—	(51.96%)
Return on assets	(64.44%)	—	(46.06%)
Return on invested capital	0.00%	—	0.00%

Metric	EPRX	YDES	Biotechnology median
Revenue growth (TTM)	—	—	4.59%
EPS growth (last fiscal year)	(35.53%)	—	29.88%
Revenue growth, 5-year CAGR	—	—	9.75%
Net income growth, 5-year CAGR	—	—	0.00%

Metric	EPRX	YDES	Biotechnology median
Debt to equity	0.01	—	0.00
Current ratio	16.00	—	4.86
Net debt to EBITDA	2.11	—	1.01

Metric	EPRX	YDES	Biotechnology median
Dividend yield	—	—	0.38%
Payout ratio	—	—	—

Metric	EPRX	YDES	Biotechnology median
Market cap	447.34m	453.04m	174.29m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack